Frankfurt - Delayed Quote EUR

SYNLAB AG (SYA.F)

9.80 0.00 (0.00%)
As of April 15 at 8:03 AM GMT+2. Market Open.
Loading Chart for SYA.F
DELL
  • Previous Close 9.80
  • Open 9.80
  • Bid 9.80 x --
  • Ask 10.20 x --
  • Day's Range 9.80 - 9.80
  • 52 Week Range 9.52 - 10.50
  • Volume 100
  • Avg. Volume 35
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.90
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers medical and veterinary diagnostics services. SYNLAB AG was founded in 1998 and is headquartered in Munich, Germany.

www.synlab.com

23,538

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Related News

Performance Overview: SYA.F

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SYA.F
0.40%
MSCI WORLD
2.94%

1-Year Return

SYA.F
--
MSCI WORLD
19.02%

3-Year Return

SYA.F
--
MSCI WORLD
19.02%

5-Year Return

SYA.F
--
MSCI WORLD
19.02%

Compare To: SYA.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SYA.F

Valuation Measures

As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.50%

  • Return on Assets (ttm)

    1.77%

  • Return on Equity (ttm)

    3.98%

  • Revenue (ttm)

    2.64B

  • Net Income Avi to Common (ttm)

    92.27M

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    265M

  • Total Debt/Equity (mrq)

    66.78%

  • Levered Free Cash Flow (ttm)

    212.86M